CSI Market
Sign In | Register

Integrated Biopharma Inc (INBP) Annual Income Statement

Annual · GAAP · USD millions
Access INBP quarterly income statements →
By examining income statement figures across successive periods, users can identify shifts in Integrated Biopharma Inc's profitability and expense structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2025)
2025 		(Jun 30 2024) (Jun 30 2023) (Jun 30 2022) (Jun 30 2021)
Revenues
Revenue From Contract With Customer Including Assessed Tax54.35
Total Revenue53.56
Costs & Expenses
Cost of Goods and Services Sold48.00
Gross Profit5.56
Selling, Administration, Marketing3.54
Other Operating Expense / -Income0.00
Total operating costs including COS51.54
Operating income / -loss2.02
Interest Expense0.00
Net Interest (-)Expense / Income0.00
Realized Investment Gains (Losses)0.00
Other loss / -income-0.04
Total costs & expenses51.50
Income & Taxes
Income / -loss before income taxes2.06
Income taxes expenses / -benefit1.25
Income after income taxes0.81
Net income / -loss of other equity0.00
Income / -loss from continuing operations0.81
Net income / -loss0.81
Income / -loss to shareholder0.81
EBIT2.06
EBITD2.36
EBITDA2.36
Earnings Per Share
Basic EPS (excl. extra items)0.03
Basic Net EPS0.03
Basic shares outstanding (Mill. of Units)30.30
Diluted Net EPS0.03
Diluted average shares (Mill. of Units)31.17
4 historic quarters locked

Sign in to unlock the full Integrated Biopharma Inc income statement history.

Sign In Create Free Account

About Integrated Biopharma Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.